CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in Glioma

Investigators used patient-derived glioma cultures and an immunocompetent murine model for malignant glioma to analyze the ability of tumor-intrinsic factors to promote a CD8+ T cell response.